Clinical Edge Journal Scan

Meta-analysis reveals that most atopic dermatitis therapies are effective against pruritus


 

Key clinical point: The majority of topical and systemic therapies for atopic dermatitis (AD) effectively reduced pruritus, the most common patient-reported symptom.

Major finding: Topical and systemic treatments led to a mean reduction of 3.32 (99% CI 2.32-4.33) and 3.07 (99% CI 2.58-3.56) points in pruritus score, respectively. Wet-wrap therapy using halometasone (−4.75 points) was the most effective topical treatment, and 30 mg upadacitinib (−4.90 points) was the most effective systemic treatment.

Study details: This study analyzed 22 studies that included patients aged ≥ 10 years with AD who received topical or systemic treatments.

Disclosures: No information on the source of funding was provided. Two authors reported ties with various organizations.

Source: Rodriguez-Le Roy Y et al. Efficacy of topical and systemic treatments for atopic dermatitis on pruritus: A systematic literature review and meta-analysis. Front Med (Lausanne). 2022;9:1079323 (Dec 22). Doi: 10.3389/fmed.2022.1079323

Recommended Reading

Age-related atopic dermatitis phenotypes evaluated in study
MDedge Dermatology
Lebrikizumab+topical corticosteroid shows promise in moderate-to-severe atopic dermatitis
MDedge Dermatology
Abrocitinib rapidly relieves itch in moderate-to-severe atopic dermatitis
MDedge Dermatology
Baricitinib offers a long-term treatment option for moderate-to-severe atopic dermatitis
MDedge Dermatology
Long-term integrated safety of baricitinib in moderate-to-severe atopic dermatitis
MDedge Dermatology
Upadacitinib is effective in treating difficult-to-treat moderate-to-severe atopic dermatitis
MDedge Dermatology
Prolonged dupilumab therapy is safe and effective in moderate-to-severe atopic dermatitis
MDedge Dermatology
Childhood atopic dermatitis is associated with increased fatigue
MDedge Dermatology
Atopic dermatitis: No association between dupilumab use and malignancy
MDedge Dermatology
Atopic dermatitis is positively linked with the risk for juvenile idiopathic arthritis
MDedge Dermatology